clinical trials

Medivir completes initial Phase Ib part of HCC therapy trial
Medivir completes initial Phase Ib part of HCC therapy trial
Clinical Trials Arena
Medvir
fostrox
Lenvima
hepatocellular carcinoma
clinical trials
Flag link:
Takeda’s Vedolizumab Clears Phase III in aGvHD
Takeda’s Vedolizumab Clears Phase III in aGvHD
BioSpace
Takeda
vedolizumab
graft vs host disease
clinical trials
Flag link:
Delaying type 1 diabetes progression: major trial readouts to watch in 2023
Delaying type 1 diabetes progression: major trial readouts to watch in 2023
Clinical Trials Arena
clinical trials
type 1 diabetes
Provention Bio
Tzeild
Diamyd Medical
remygen
Imcyse
IMCY-0098
ProKidney
Flag link:
Gilead reports positive data from urothelial cancer therapy trial cohorts
Gilead reports positive data from urothelial cancer therapy trial cohorts
Clinical Trials Arena
Gilead Sciences
Trodelvy
metastatic urothelial cancer
clinical trials
Flag link:
Pfizer, Valneva remove half of participants from study of Lyme disease shot
Pfizer, Valneva remove half of participants from study of Lyme disease shot
BioPharma Dive
Pfizer
Valneva
clinical trials
vaccines
Lyme disease
VLA15
Flag link:
Moderna checks a few boxes in phase 3 mRNA flu shot trial, but misses on B strains and safety
Moderna checks a few boxes in phase 3 mRNA flu shot trial, but misses on B strains and safety
Fierce Biotech
Moderna Therapeutics
clinical trials
MRNA
vaccines
Flu
flu vaccines
Flag link:
Sanofi and Regeneron face a high-risk test for Dupixent
Sanofi and Regeneron face a high-risk test for Dupixent
EP Vantage
Sanofi
Regeneron
Dupixent
COPD
clinical trials
Flag link:
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
Fierce Pharma
Merck
Keytruda
clinical trials
stomach cancer
Flag link:
HistoSonics’ Kidney Cancer Trial Using Non-Invasive Histotripsy Gets FDA Nod
HistoSonics’ Kidney Cancer Trial Using Non-Invasive Histotripsy Gets FDA Nod
Xtalks
HistoSonics
FDA
devices
Medtech
histotripsy
kidney cancer
clinical trials
Flag link:
AlloVir's cell therapy tackles infection in midphase kidney transplant trial
AlloVir's cell therapy tackles infection in midphase kidney transplant trial
Fierce Biotech
AlloVir
kidney transpants
clinical trials
Flag link:
Study: 10% of FDA approved drugs since 2018 had pivotal trials that missed primary endpoints
Study: 10% of FDA approved drugs since 2018 had pivotal trials that missed primary endpoints
RAPS.org
FDA
drug approvals
clinical trials
Flag link:
Frequency Therapeutics reports trial fail and lays off over half of staff — stock capsizes
Frequency Therapeutics reports trial fail and lays off over half of staff — stock capsizes
Endpoints
Frequency Therapeutics
layoffs
clinical trials
hearing loss
Flag link:
Incyte reports new data from hidradenitis suppurativa therapy trial
Incyte reports new data from hidradenitis suppurativa therapy trial
Clinical Trials Arena
Incyte
clinical trials
hidradenitis suppurativa
povorcitinib
Flag link:
Leo Pharma announces positive results for hand eczema study
Leo Pharma announces positive results for hand eczema study
Pharmaphorum
LEO Pharma
clinical trials
eczema
chronic hand eczema
delgocitinib
Flag link:
Galapagos' Jyseleca flops phase 3 Crohn's study, dealing another blow to troubled JAK inhibitor
Galapagos' Jyseleca flops phase 3 Crohn's study, dealing another blow to troubled JAK inhibitor
Fierce Pharma
Galapagos
FDA
filgotinib
Crohn's Disease
clinical trials
Jyseleca
Flag link:
FDA hands down a partial hold for PhI/II trial of Blueprint’s CDK2 inhibitor
FDA hands down a partial hold for PhI/II trial of Blueprint’s CDK2 inhibitor
Endpoints
FDA
Blueprint Medicine
clinical trials
solid tumors
BLU-222
Flag link:
Medable and Nova Scotia Health Partner to Improve Oncology Trial Access Through Decentralized Clinical Trial Technology
Medable and Nova Scotia Health Partner to Improve Oncology Trial Access Through Decentralized Clinical Trial Technology
Xtalks
clinical trials
Medable
Nova Scotia
oncology
decentralized clinical trials
Flag link:
Trials cue up new use for Roche's eye disease drug Vabysmo
Trials cue up new use for Roche's eye disease drug Vabysmo
Pharmaphorum
Roche
Vabysmo
clinical trials
retinal vein occlusion
Flag link:
Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy
Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy
Pharmaphorum
Novo Nordisk
Heartseed
clinical trials
HS-001
cell therapy
heart failure
Flag link:
Bayer begins key tests for closely watched blood thinner
Bayer begins key tests for closely watched blood thinner
BioPharma Dive
Bayer
clinical trials
bloodthinners
asundexian
Flag link:

Pages